查看完整行情页>>

|

货币单位:美元(USD)

Cepheid公司

Cepheid (cphd)

实时(?):
盘后(?):
读取中...
  • -- (--%)
开盘价:-- 最高价:-- 最低价:-- 52周最高价:-- 52周最低价:--
成交量:-- 平均成交量:-- 市值:-- 市盈率:-- 预期市盈率:--
每股收益:-- 贝塔系数:-- 股息:-- 收益率:-- 总股本:--
David H. Persing David H. Persing is currently the Chief Medical & Technology Officer at CEPHEID since 2004. Prior to this, he worked as the Director at Monogram Biosciences, Inc. from 2000 to 2009. He was also the Chief Scientific Officer & Senior Vice President at Corixa Corp. from 1999 to 2005 and a Member at The Mayo Clinic (Old) from 1990 to 1999. He has also served as a Director at ASM Resources, Inc. Dr. Persing completed his undergraduate degree from San Jose State University and received his doctorate from The University of California, San Francisco in 1988.
Melissa Aquino Melissa Aquino is currently the Chief Executive Officer at CEPHEID. Prior to this, she worked as the Head of Danaher Business System at Danaher Corp.
Deborah Gonyea Deborah Gonyea has a current job as the Chief Financial Officer at CEPHEID.
Vitor Rocha Vitor Rocha is currently the Chief Executive Officer at Philips Electronics North America Corp. and also serves as a Director at Advanced Medical Technology Association. He is also a Director at C.T. Holmes & Co. Ltd. and the President at CEPHEID. Previously, he worked as an Executive Vice President at Koninklijke Philips NV. Mr. Rocha holds a Master's in Business Administration from The Pennsylvania State University and an undergraduate degree from Pontifícia Universidade Católica de São Paulo.